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Abstract
Background: Helicobacter pylori, a human pathogen associated with chronic gastritis, peptic ulcer and gastric malignancies,
is generally viewed as an extracellular microorganism. Here, we show that H. pylori replicates in murine bone marrow
derived-dendritic cells (BMDCs) within autophagosomes.
Methodology/Principal Findings: A 10-fold increase of CFU is found between 2 h and 6 h p.i. in H. pylori-infected BMDCs.
Autophagy is induced around the bacterium and participates at late time points of infection for the clearance of intracellular
H. pylori. As a consequence of infection, LC3, LAMP1 and MHC class II molecules are retained within the H. pylori-containing
vacuoles and export of MHC class II molecules to cell surface is blocked. However, formalin-fixed H. pylori still maintain this
inhibitory activity in BMDC derived from wild type mice, but not in from either TLR4 or TLR2-deficient mice, suggesting the
involvement of H. pylori-LPS in this process. TNF-alpha, IL-6 and IL-10 expression was also modulated upon infection
showing a TLR2-specific dependent IL-10 secretion. No IL-12 was detected favoring the hypothesis of a down modulation of
DC functions during H. pylori infection. Furthermore, antigen-specific T cells proliferation was also impaired upon infection.
Conclusions/Significance: H. pylori can infect and replicate in BMDCs and thereby affects DC-mediated immune responses.
The implication of this new finding is discussed for the biological life cycle of H. pylori in the host.
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Introduction
Helicobacter pylori is a Gram-negative, spiral-shaped, microaero-
philic bacterium which colonizes the gastric mucosa. Infection
occurs worldwide and is correlated with socioeconomic condition
[1]. The prevalence among middle-aged adults is over 80 percent
in many developing countries, as compared with 20 to 50 percent
in industrialized countries. Overt diseases, however, occur in only
10–20% of infected individuals. It plays a causative role in chronic
gastritis, peptic ulcer disease and is strongly associated with the
development of gastric adenocarcinoma and mucosa-associated
lymphoid tissue lymphoma [2]. The histopathological hallmarks of
H. pylori-induced disease are a massive inflammatory cell
infiltration of the lamina propria and erosion of the gastric
epithelium. The gastric mucosa is well protected against bacterial
infections. However, H. pylori is able to adapt and reside in the
mucus, attach to epithelial cells, evade immune responses, and
achieve persistent colonization in the stomach. It is not clear why
the immune system fails to clear H. pylori infection. Furthermore,
the mechanisms controlling the induction and maintenance of the
H. pylori-induced chronic inflammation are only partly understood
[3]. H. pylori is generally viewed as an extracellular pathogen
colonizing the luminal side of the gastric epithelium and inducing
an immune-inflammatory response on the stroma side of the
mucosa. Paradoxically, H. pylori-specific gastric mucosal T cells
generally present a Th 1 phenotype. It has been shown that Th1
cytokines promote gastritis, whereas Th2 cytokines are protective
against gastric inflammation [4]. DCs are potent antigen-
presenting cells that initiate T-cell responses. An abnormal pattern
of DC maturation could promote chronic inflammatory processes
[5]. Thus, the dysfunction of DCs may contribute to the local
inflammation by producing inflammatory mediators and inappro-
priate activation of T cells.
Virulent H. pylori is capable of escaping phagocyte killing by
delaying phagosome formation [6,7]. However, we have reported
the Taiwan clinical isolates such as HP238 and HP250, not only
survive but also replicates in human macrophage cell line THP-1
cells [8]. In this study, we further extend this research to show that
H. pylori can multiply in BMDCs, and impair the function of
BMDC.
Results
Replication of H. pylori in murine BMDCs
H. pylori can multiply in macrophage autophagosomes [8]. To
extend to DC, murine BMDC were infected with HP238 at a
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MOI of 10 for 1 h. Gentamycin was used to kill extracellular H.
pylori for another 1 h. After gentamicine treatment, the cells were
washed with PBS for 3 times and then cultured for additional 6, 12
and 24 h. At various time points post-infection (p.i.), BMDC were
lysed, and viable H. pylori were re-cultured and plate-counted on a
CDC plate for colony forming units (CFU) determination. As
shown in Fig. 1A, CFU counts at 2 h p.i. corresponded to the
amount of internalized live H. pylori. At 6 h p.i., a 10-fold
increment was observed indicating that internalized H. pylori
underwent replication. The number of live H. pylori gradually
decreased at 12 h till 24 h p.i., suggesting that BMDCs gradually
cleared the bacteria. The extracellular H. pylori was killed by the
gentamicin, no viable H. pylori can be cultured from supernatant at
6, 12 and 24 h p.i. (data not shown). The role of VacA or CagA
was also evaluated. The cagA and vacA mutants were also able to
replicate in BMDC, but were cleared at a faster rate than wild
type. No viable H. pylori could be recovered at 24 h p.i. (Fig. 1A).
H. pylori-associated autophagy in infected murine BMDCs
Replication of H. pylori in murine BMDCs was examined under
transmission electron microscopy. Intracellular H. pylori were
found surrounded by a double layer membrane at 2, and 6 h p.i.
(Fig. 1B-b,c), a characteristic of autophagosomes. Dividing H.
pylori could also be observed in double-layer large membrane
vacuoles (Fig. 1B-f). At 12 h p.i., several autophagosomes fused
with lysosomes to form a onion-like structure of multiple layer
vesicles (Fig. 1B-e) and bacteria degradation were observed at
24 h p.i. (Fig. 1B-d). The autophagic marker LC3-II co-localized
with the H. pylori-containing vacuole at 2 h p.i. (Fig. 2A).
Increased numbers and densities of LC3 punctate staining were
associated with replicating H. pylori at 6 h p.i., but gradually
decreased at 24 h p.i. On Western blot analysis, the signaling
molecules such as LC3 II conversion, BNIP3 formation, but not
in Beclin1, were also found to increase after infection compared
to uninfected cells (Fig. 2B). The p62 was induced at 2 h p.i., and
Figure 1. Multiplication of H. pylori in BMDC cells. (A) Multiplication of H. pylori in BMDCs. BMDCs infected with HP238 wild type, VacA or CagA
mutants at m.o.i. = 10 for 2, 6, 12 and 24 h were lysed and intracellular bacteria were quantified at different time points after inoculation. The
recovered viable H. pylori were determined as CFU on CDC plate. (B) Ultrastructural alterations in H. pylori-infected BMDCs. At 2 h (b, c), 6 h (d, g),
12 h (f), and 24 h (e) post infection, infected cells were collected for EM examination. (a) shows the mock samples without H. pylori infection. (g)
shows the dividing bacteria at 6 h p.i. ‘HP’ indicates the location of H. pylori within BMDCs. Closed arrows indicate the double-layer structure whereas
opened arrows indicate digested bacteria. (f) shows the multivesicular structure (MV) and lysosome (L) at 12 h p.i. * p,0.05 via student t-test.
doi:10.1371/journal.pone.0010844.g001
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degrade gradually till 24 h, p.i., indicating that an autophagic
flux was induced post infection. This suggests that H. pylori
infection induces autophagy and autophagosomes seem to be the
site in which H. pylori transiently replicate before degradation by
autophagolysosome.
Membrane trafficking of H. pylori and impairment of MHC
class II molecule surface expression
A delayed phagosome maturation associated to the formation of
megasomes was reported to delay the clearance of H. pylori in
macrophages [7]. Therefore, H. pylori trafficking in murine
BMDCs was studied by confocal microscopy. H. pylori was
detected in EEA1 early endosome-positive vacuoles at 2 h p.i..
Then, H. pylori wild type, cagA and vacA mutants were found in a
LAMP-1-positive compartment at 24 h p.i. (Fig. 3B). At 48 h p.i.,
loss in the intensity of anti-H. pylori antibody staining was observed
indicating that H. pylori had started to be degraded (Fig. 3A).
DCs are the most potent antigen presenting cells. Activated DCs
express activation molecules, such as CD80 and CD86 and MHC
class II molecules on the cell surface to present antigenic peptides
to activate T cells. In H. pylori-infected murine BMDCs, MHC
class II molecules were not transported to the cell surface and
accumulated in the cytoplasm (Fig. 4A). In fact, MHC molecules
were found to localize with the H. pylori-containing vacuoles
(Fig. 4B). Under these conditions, H. pylori infection also impaired
the IFN-c -induced up-regulation of MHC class II expression.
MHC class II molecule transport to cell surface was also defective
in formalin-fixed H. pylori infected BMDCs. Since the formalin-
fixed H. pylori is not capable of replicating, this suggests that H.
pylori replication is not a prerequisite for the block of class II
Figure 2. H. pylori infection in BMDCs induces autophagy. (A) BMDCs were infected with HP238 at m.o.i. = 10. At 2, 6, and 24 h post infection,
the infected cells were stained with anti-H. pylori antibodies (red) and LC3-II antibodies (green). (B) LC3-II conversion and autophagic flux in H. pylori-
infected BMDCs. BMDCs were infected with H. pylori at m.o.i. = 10 for 2, 6, 12 or 24 h post infection, protein samples were collected for LC3-II, p62,
Beclin1, BNIP3 and b-actin analysis by Western blot.
doi:10.1371/journal.pone.0010844.g002
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molecule transport to cell membrane (Fig. 4C). We used flow
cytometry to stain the surface expression of MHC class I, II
molecules and CD80 and CD86 in H. pylori-infected BMDC. The
IFN-c was used as a positive control to enhance the surface
expression of MHC class I and II molecules, CD80 and CD86.
MHC class I expression was enhanced after H. pylori infection and
the addition of IFN-c further increased MHC class I expression,
indicating that H. pylori indeed activated MHC class I expression
in BMDC. In contrast, MHC class II, CD80 and CD86 surface
expression remained at the same level as untreated control
immature cells (Fig. 4D). H. pylori infection also down-regulated
the IFN-c enhanced MHC class II, CD80 and CD86 surface
expression. Interestingly, formalin-fixed H. pylori infection induced
the same activities as untreated bacteria. Therefore, transport of
MHC class II molecules from the cytoplasm to the plasma
membrane seems to experience interference from the presence of
the H. pylori, either viable or formalin-fixed.
H. pylori infection stimulates murine BMDCs to secrete
TNF-a, IL-6 and IL-10, but not IL-12
The cytokine secretion pattern after H. pylori infection was
further analyzed at 24 h p.i.. Salmonella enteric serovar Thyphi-
murium infection was used as a positive control. TNF-a and IL-6
secretion in supernatants from H. pylori or formalin-fixed H. pylori
infected cells were found to be similar (Fig. 5A). Interestingly, IL-
10 secretion required BMDCs stimulated by live H. pylori only. No
IL-12 secretion was observed from the H. pylori-infected BMDCs
(Fig. 5A-d). The vacA and cagA mutants were also tested for the
production of IL-12. These mutants also failed to produce IL-12
(Fig. 5A-e). These results suggest that H. pylori infection impairs the
activation and maturation of DCs, probably by down regulating
the secretion of pro-iflammatory cytokines such as IL-12 and, in
the case of live bacteria by promoting the secretion of IL-10.
Negative role of TLR4 or TLR2 on the BMDC maturation
post H. pylori-infection
H. pylori LPS uses both TLR4 and TLR2 for cell activation [9].
Hence, we compared H. pylori infection in BMDCs derived from
TLR4-deficient C3H/HeJ mice and in C3H/HeN control mice.
Although the presence of H. pylori in BMDC from TLR4-deficient
C3H/HeJ mice is slightly lower than that from C3H/HeN mice
(Figure S1A), H. pylori can replicate in TLR4-deficient BMDC.
However, the MHC class II surface expression in infected TLR4-
deficient BMDCs is not inhibited (Fig. 6B) and no co-localization
of MHC class II molecules with H. pylori-containing vesicles was
found (Fig. 6A). For cytokine production, TNF-a and IL-6
secretion were lower in infected TLR4-deficient BMDC than in
wild type BMDC. However, IL-10 secretion was higher in TLR4-
deficient BMDC than in wild type BMDC (Fig. 5B). No IL-12
production was detected for both BMDCs (data not shown).
We also compared DC activities in wild type versus TLR2
knockout mice. H. pylori can replicate in BMDCs derived from
either TLR2 wild type or TLR2-/- (Figure S1B). In TLR2-/-
BMDC, MHC class II surface expression inhibition was transient,
found only at 24 h p.i. Then, an enhanced surface expression of
MHC class II molecules was observed at 48 h p.i.(Fig. 6C). The
cytokine expression was also modulated in TLR2-/-. TNF-a and
IL-6 were lower in TLR2-/- BMDC than in wild type BMDC.
However, in contrast to what is observed in TLR4-deficient mice,
IL-10 was not detected in the supernatants of TLR2-/- infected
BMDC (Fig. 5C).
Finally, we assayed antigen presentation in H. pylori-infected
BMDC to H. pylori-specific T cells. Lymph node T cells derived
from H. pylori-immunized mice were stimulated with H. pylori-
infected BMDC in a ratio of 1:5 and the BrdU incorporation was
determined. Comparing with the H. pylori-infected TLR2-/-
BMDC that has an increased MHC class II molecule surface
expression post-infection, H. pylori-induced T cell proliferation by
wild type BMDC was significantly lower than that of TLR2-/-
BMDC (Fig. 6D). Whether H. pylori infected BMDC, killed H.
pylori-treated BMDC, or IFN-c treated H. pylori-infected BMDC,
the same pattern was displayed, indicating that H. pylori-treated
BMDC showed a defect in antigen presentation.
Figure 3. H. pylori in LAMP1+ vesicles within BMDCs. (A) The
endocytic trafficking of H. pylori within BMDCs. BMDCs were infected
with HP238 at m.o.i. = 10. At 2, 24, or 48 h post infection, the infected
cells were stained with anti-H. pylori antibodies (green), anti-EEA1
antibody (blue), or anti-LAMP1 antibodies (red). Confocal images show
the localization of H. pylori with EEA-1+ or LAMP-1+ vesicles. Closed
arrows indicate EEA-1+ H. pylori-containing vesicles, opened arrows
indicate LAMP-1+ H. pylori-containing vesicles and triangles indicate the
digested bacteria particles. (B) H. pylori can replicate in LAMP1+ vesicles
within BMDCs. BMDCs were infected with HP238 wild type, vacA
(vacA::cm) and cagA (cagA::cm) mutant at m.o.i. = 10. At 2, 8 and 24 h
post infection, the infected cells were stained with anti-H. pylori
antibody (green) and anti-LAMP-1 antibodies (red). Confocal images
show the localization of H. pylori on LAMP1+ vesicles. The closed arrows
indicate the bacteria without LAMP-1 surround and the opened arrows
show H. pylori+ and LAMP-1+ vesicles.
doi:10.1371/journal.pone.0010844.g003
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Discussion
We have demonstrated here that H. pylori is capable of
multiplying in BMDCs after invasion. A 10-fold increase of
CFU between 2 h and 6 h p.i. is found in H. pylori-infected
BMDCs. The doubling time of the H. pylori in BMDC cells was
calculated to be 1.5–2 h. Autophagy is induced by H. pylori and the
double-membrane autophagosomes is associated H. pylori after its
invasion. Then, the H. pylori-containing autophagosomes fuse with
lysosomes to lead to degradation of the bacteria. The finding of
this transient replication of H. pylori in BMDCs suggests that H.
pylori can be considered as a facultative intracellular microorgan-
ism under certain condition. Moreover, its multiplication in
BMDCs would impair the functions of the dendritic cells.
H. pylori is generally viewed as a non-invasive pathogen localized
only in the lumen of the stomach and attached to gastric epithelial
cells. It has adapted several mechanisms to reside and persist in the
mucus, avoid phagocytosis and evade immune responses. The
phagocytosis process is retarded and the membrane trafficking of
phagosome maturation is disrupted to form a megasome that
contains the ingested bacteria [6,7]. Many reports have shown that
H. pylori is invasive, and can be considered a facultative
intracellular organism [10,11]. However, no direct demonstration
of its replication by plaque counting in infected cells has so far
Figure 4. MHC class II cell surface expression is inhibited by H. pylori. BMDCs were infected with H. pylori at m.o.i. = 10. At 2, 24, or 48 h post
infection, the infected cell was stained with anti-class II antibody only (A) or anti-H. pylori antibody (green), anti-LAMP-1 antibody (red), or anti-class II
antibody (blue) (B). Confocal images (arrow) shows MHC class II expression on the infected BMDCs. Arrows show the MHC class II accumulated in
cytoplasm (A). Confocal images show the co-localization of H. pylori, LAMP-1 and MHC class II molecules on infected BMDCs at 24 and 48 h post
infection (B). (C) H. pylori-infected cells were stained with anti-class II antibody (green) and anti-H. pylori antibodies (red), and DAPI (blue). Confocal
images shows MHC co-localization of class II and H. pylori-containing vesicle on various treatment groups (mock control, IFN-c treatment, H. pylori
infected, H. pylori with IFN-c or formalin fixed-H. pylori) at 24 h post treatment. (D) Surface class II expression on H. pylori-infected BMDCs. H. pylori-
infected cells were surface stained with anti-class I, class II, CD80, or CD86 antibody, and analyzed with Flow cytometry. The percentage of stained
antibody positive cells is depicted.
doi:10.1371/journal.pone.0010844.g004
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been provided. We have found that H. pylori could multiply not
only in macrophages [8], and in epithelial cells (data not shown),
but also in BMDCs as shown in this study. Two Taiwanese clinical
isolates of HP238 (from gastric adenocarcinoma specimen) and
HP250 (from mucosa-associated lymphoid-tissue lymphoma
speciment) can multiply in macrophage cell line THP-1 [8]
whereas standard strains of ATCC43504 and J99 can multiply in
AGS or MKN45 epithelial cell line (unpublished data). For
BMDCs, only HP238 is found to replicate in this study. This new
finding has several implications for the biological life cycle of H.
pylori in the host, especially considering the role of DC as
controllers of the immune responses. Wunder et al. reported that
H. pylori is auxotrophic for cholesterol, and can extract cholesterol
from epithelial membrane. The glycosylation of cholesterol would
inhibit the phagocytosis of H. pylori and promote its immune
evasion [12]. Cholesterol has been found to play an essential role
in the establishment of the chronic infection of intracellular
microorganisms, in that the phagosomal lipid metabolism of the
host macrophage was modulated by the virulent factors of the
bacteria to favor the survival of the invading bacteria [13–15]. H.
pylori can also infect the AGS cells via a sipper-like mechanism,
involving intimate contact with AGS cells microvilli and surface
membrane pseudopod structure. The internalized H. pylori are
found in LAMP-1-containing vacuoles [16]. Cytoskeletal rear-
rangement with tyrosine phosphorylation was observed in the
promixity of intracellular H. pylori. We found that H. pylori
infection induced autophagosome formation in either phagocytic
THP-1 cells, BMDC, or non-phagocytic AGS epithelial cells. H.
pylori resides and replicates within autophagosomes, probably
reflecting its dependence on the cell membrane probably because
of its cholesterol requirement for growth. The CagA can be
translocated to plasma membrane and form rafts with the invading
H. pylori [17]. In our study, Cag A or VacA mutants can still
replicate in BMDC, but were cleared in a fast rate probably due to
the interference in the autophagosome formation by Cag A or
VacA. This needs further investigation. Rittig et al reported the H.
pylori-induced homotypic phagosome fusion is independent of the
VacA or Cag A in human monocytes [18]. Since we used murine
BMDC, whether H. pylori can replicate in human dendritic cells
need to be checked in the future.
In view of the observation that H. pylori infection induces
autophagy, there remains the question as to what role autophagy
plays in the defense against H. pylori. Autophagy has been found to
be a component of the innate cellular immune responses against
not only intracellular but also against extracellular microorganisms
[19,20]. After phagocytosis of the microorganism, the autophago-
somes will be formed to degrade the ingested bacterium by the
lysosomal killing mechanism. The intracellular bacteria such as
Legionella pneumophila, Listeria monocytogenes, Mycobacterium, and Shigella
have developed different mechanisms to evade the autophagic
cellular surveillance in macrophage. The double membrane-
bound compartments that bear autophagic markers were induced,
but its maturation into autophagolysosomes will be arrested or
delayed. Allen et al. have reported the megasome formation
induced by H. pylori via homotypic phagosome fusion to delay its
clearance in macrophage [6,7]. However, for the H. pylori-induced
autophagosome, the autophagosome not only provides the site for
replication, but also the place for the destruction of the replicating
bacterium. After phagocytosis into BMDC, H. pylori co-localized
with EEA1 early endosomal marker and then with the LAMP1+
Figure 5. TNF-a, IL-6, IL10 and IL-12p70 production of H. pylori-infected BMDCs. Cytokine production in H. pylori-infected BMDCs derived
from B6 mice (A), TLR4 deficient mice (B), or TLR2 knock out mice (C). BMDCs were infected with H. pylori at m.o.i. = 10. At 24 h post infection, the
supernatants were collected from medium alone (mock), H. pylori, formalin fixed-H. pylori or Salmonella treated BMDCs and the TNF-a (a), IL-6 (b), IL-
10 (c), and IL-12p70 (d,e) concentrations were determined. In (e), the vacA (VacA::cm), cagA (CagA::cm) mutants were included for comparison. (B &C)
TNF-a, IL-6, and IL-10 production in H. pylori-infected BMDCs derived from wild type, TLR4 deficient, or TLR2 knock out mice, the cytokines
concentration were determined at various hour post infection. * p,0.05 via student t-test.
doi:10.1371/journal.pone.0010844.g005
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Figure 6. TLR 2 or TLR4 negatively regulate H. pylori-mediated inhibition of MHC class II surface expression and antigen
presentation. BMDCs derived from TLR4 deficient C3H/HeJ (A & B) or TLR2 knock-out B6 mice (C) were infected with H. pylori at m.o.i. = 10. The MHC
class II expression was detected on confocal microscopy (A) or flow cytometry (B) at 24 h post inoculation. In A & B, the wild type (C3H/HeN) was
compared to the TLR 4 deficient (C3H/HeJ) mice. In C, the B6 wild type was compared to the TLR2 knock out mice. (D) Antigen-specific T cell
H. pylori in Dendritic Cells
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late endosomal/lysosomal marker (Fig. 3). Multiple vesicle
vacuoles formed at 12–24 h p.i. that subsequently resulted in the
destruction of the bacteria due to fusion with lysosomes (Fig. 1B).
IFN-c treatment enhanced the clearance of the H. pylori also
supporting the notion that autophagy helps the clearance of
internalized H. pylori in the endosome/autophagosome after fusion
with lysosomes (Figure S2).
TLRs are involved in the innate immune response to H. pylori
infection [9,21–23]. H. pylori has adapted its LPS structure for
colonization, adhesion and escaping from immune responses. The
phase-variable expression of these Lewis antigens seems to affect
the induced immune response by modulation of cell activation
through DC-SIGN. LeX antigen negative expressed H. pylori
escape binding to dendritic cells and induce a strong Th1
response. In contrast with LeX antigen negative expression, H.
pylori variants that express LeX/LeY can bind to DC-SIGN on
dendritic cells and enhance the production of IL-10 which
promote Th2 response [24,25]. Cell activation by H. pylori LPS
has been shown to be both TLR2- and TLR4-dependent,
although less stimulatory than E. coli LPS, and sometime
antagonistic for TLR4 [26–28]. For H. pylori LPS, TLR2 is
primarily activated [21,28], and induces the production of IL-10,
also skewing the immune response to Th2 arm [9,25,29,30]. In
our study, the secretion of TNFa and IL-6 was inhibited in TLR4-
and TLR2-deficient BMDCs, indicating that both TLR2 and
TLR4 participate in the response to H. pylori LPS. Intriguingly, IL-
10 production was enhanced in TLR4-deficient BMDCs, but
completely abolished in TLR2-/- BMDCs. TLR4 was reported to
negatively regulate the fusion between phagosomes and lysosomes
in macrophage for the degradation of the engulfed antigen [31].
IL-10 has been found to down-regulate the MHC class II export to
plasma membrane, probably via inhibition of cathepsin S [32,33].
How the H. pylori components interfere with the MHC class II
molecules transport to cell surface is intriguing. VacA is initially
characterized as its ability to induce the formation of intracellular
vacuoles in cell lines, and has been found to decrease the pH value
of acidic vesicle. Molinari M., et al., demostrated VacA interferes
the Ii-dependent pathway of antigen presentation in B cells [34].
During the phagosome maturation, the VacA-containing H. pylori
or VacA recruit and retain the coronin 1 to disrupt the phagosome
maturation and inhibit the antigen presentation [34,35]. The
urease of H. pylori can also bind to CD74 (the class II-associated
invariant chain that regulate the intracellular transport and
functions of class II) to affect the cell motility of dendritic cells
[36], or cause megasome formation [37]. In addition, several
molecules such as RP105, ST2, SIGIRR, or Galectin-3 have been
reported to regulate the TLR4 or TLR2 signaling negatively [38–
43]. In our study, surface MHC class II molecules, or even after
IFN-c-treatment, were down-regulated by H. pylori infection in
BMDCs. The formalin-fixed and heat-killed H. pylori can still
remain the inhibition of the MHC class II expression. The MHC
class II molecule seems to be trapped in H. pylori containing
vesicles. The TLR-2 and 4 signaling also play a negative role on
the class II surface expression. It must be a multiple factors
involvement. The Ii, urease, IL-10, TLR2/4 signaling will all
contribute to the inhibition of class II export and these are under
current investigation.
DC can phagocytose and process bacteria for antigenic peptide
presentation by MHC class II molecules to specific T cells. DCs
are activated and secrete IL-12, which favors the differentiation of
splenocytes into Th1 [4,27,44–46]. Inhibition of IL-12 secretion
by H. pylori was also reported [47,48]. In this study, IL-10, but not
IL-12, was detected after H. pylori infection. In addition, MHC
class II molecule export to the cell surface is blocked, which results
in an impaired antigen presentation. This will favor the induction
of a non-Th1 response. A complexity of interaction between H.
pylori and host immune defenses is responsible for the persistence of
H. pylori infection [3]. For H. pylori, Th1 has been supposed to be
protective as well as immunopathogenic, which is paradoxical.
CD8+ T cells are also activated and are associated with severe
gastritis in H. pylori-infected mice [49]. The replication of H. pylori
within the cells can explain the endogenous antigen presentation
and activation of CD8+ T differentiation post infection. In
conclusion, the finding that H. pylori can multiply in dendritic
cells will add a new element to the complexity of the immune
responses to the H. pylori infection, and shed light on further
understanding of immunopathology in H. pylori-induced disease.
Materials and Methods
Bacterial strains and culture
The H. pylori clinical isolate (HP238) was obtained from the
Department of Pathology, National Cheng Kung University
Hospital. The mutant of cagA and vacA were used as previously
described [8]. H. pylori were grown on CDC anaerobic 5% sheep
blood agar plates (BBL, Becton-Dickinson, USA) under micro-
aerophilic conditions (5% O2, 10% CO2, 85% N2) and 85%
humidity in a Nuaire incubator (Plymonth, Minnesota, USA) at
37uC. Fresh plates were started from glycerol stocks and
subculture every 48 hours. In bacterial replication assays, the
strain used in this study were HP238, and its vacA or cagA isogenic
mutants [8] at a multiplicity of infection of 1:10. Bacteria were
centrifuged onto BMDCs at 400 g for 6 min at 4uC and incubated
at 37uC with 5% CO2 atmosphere one hour. After washed with
phosphate-buffer saline (PBS) for 3 times, the cells were incubated
with 5% FBS, 100 mg/ml gentamicin RPMI1640 media at 37uC
for another one hour. After gentamicine treatment, the cells were
washed with PBS for 3 times and then cultured with dendritic cell
culture media for 6, 12 and 24 h. After co-incubation of BMDC
with H. pylori for 6, 12 or 24 h, BMDC were lysed with 0.5 ml of
0.1% saponine (in DPBS) and then plated on CDC plates with
serial dilution to determine the viable bacteria. Colonies were
grown and counted after 7 days culture. The time point of 2 h is
considered as the entry of H. pylori into the cells. The increase of
CFU at 6 h is interpreted as result from multiplication of H. pylori
within the cells. There was no viable bacterial cultured from
supernatant post 6, 12 and 24 h post infection (p.i.). Bacteria were
treated with 4% formalin for 10 min and then washed 3 times with
PBS. H. pylori was heat-killed at 95uC for 20 min.
Bone marrow-derived dendritic cells culture
Bone marrow cells were collected from the bones of 6-10-week
old C57BL/6 (wild and TLR2 knockout) mice, C3H/HeN or
C3H/HeJ female mice. The 1.66106/well cells were cultured in
6-well plate with RPMI1640 media containing 10% fetal bovine
proliferation. BMDCs derived from B6 or TLR2-/- mice were infected with H. pylori, heat-killed H. pylori, or IFN-c plus H. pylori for 24 h. Then BMDCs
were mixed with H. pylori-primed lymph node cells at a 1:5 ratio. The T cell proliferation was determined after 5 days by BrdU cell proliferation ELISA
kit. The absorbance at 450 nm was depicted. Wild type (&) and TLR2-/- ( ) BMDCs were compared for their antigen presentation to H. pylori-specific
T cells. H. pylori-stimulated wild type BMDCs have lower antigen presentation than that of TLR2-/-. * p,0.05 via student t-test.
doi:10.1371/journal.pone.0010844.g006
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serum, 50 mM 2-mercaptoethanol and 20 ng/ml mouse recombi-
nant GM-CSF at 37uC for 5 days to differentiate into dendritic
cells. The media were replaced with fresh media on 3rd day. The
mice were maintained in the pathogen-free facility of the Animal
Laboratory of National Cheng Kung University (Tainan, Taiwan)
that were raised and cared for according to the guidelines set up by
the National Science Council, ROC. The use of mouse
experiments were approved by the institutional animal care and
use committee of NCKU.
Flow cytometry
BMDC were infected with H. pylori at m.o.i. = 10 at 37uC for
1 h and then washed and treated with 100 mg/ml gentamicin. The
infected cells were harvested at different times post infection, and
were stained with anti-class I, class II, CD80, and CD86 antibody
(eBioscience, USA) on ice for 30 min and then washed with wash
buffer. The percentage of antibody positive cells was analyzed by
the FACSCalibur flow cytometry system.
Immunofluorescence confocal microscopy
BMDC were incubated with either H. pylori, or formalin-fixed
H. pylori for 1 h, then washed and treated with 100 mg/ml
gentamicin. For the IFN-c treated groups, recombinant mouse
IFN-c (100 U/ml) was added after the gentamicin treatment step,
and were then fixed with 3% paraformaldehyde, pH 7.4, at room
temperature for 10 min, and washed with phosphate buffer saline
3 times. The primary antibodies used were: rabbit anti-H. pylori
antibody (ABR, USA), mouse anti-H. pylori (Abcam, UK), rabbit
anti-LC3 II antibody (Abgent, USA); rat anti-lysosomal-associated
membrane glycoprotein 1 (LAMP-1) antibody 1D4B (eBioscience,
USA); goat anti-human EEA-1 antibody (Santa Cruz, USA), and
rabbit anti-MHC class II antibody. The secondary antibodies used
were: FITC-conjugated goat anti-rabbit, TexRed-conjugated
donkey anti-rat and cyanin-5-conjugated anti-goat antibodies.
Samples were observed on a Zeiss LSM 510 laser scanning
confocal microscope for image acquisition.
Cytokine detection
Supernatants were collected from medium alone (mock) or
bacterial infected groups after inoculation. TNF-a, IL-6, IL-10,
and IL-12p70 concentrations were detected by ELISA kit (R&D,
USA).
Western blot analysis
The cells were harvested at different times post infection, and
lysed in lysis buffer (25 mM Tris, 137 mM NaCl, 10% (v/v)
glycerol, 0.5% (w/v) sodium deoxycholate, 2 mM EDTA)
containing protease inhibitors (1 mM phenylmethylsulfonyl fluo-
ride, 30 mg/ml aprotonin, 1 mM sodium orthovanadate). Lysates
were clarified by pipetting and vortex at 4uC, 30 min. Insoluble
material was removed by 12,000 rpm centrifuge. Protein concen-
trations were determinate by Bio-Rad protein detection kit. Equal
amounts of protein were loaded on a 12% SDS-PAGE, transferred
to nitrocellulose membrane. Anti-Beclin 1 (Santa Cruz, CA),
BNIP3 (Sigma, USA), p62 (Abgent, USA), LC3 II (Abgent, USA)
and GAPDH (Abcam, Cambridge, UK) antibodies were used to
detect protein expression patterns. After incubation with perox-
idase-conjugated secondary antibodies, the blots were visualized
by enhancing chemiluminescence reagents (Perkin Elmer Life
Sciences, Boston, MA).
Transmission electron microscopic examination
For ultrastructural analysis, H. pylori infected cells at different
time points were fixed with 4% glutaraldehyde and post-fixed in
1% OsO4. The cells were observed under transmission electron
microscopy (Hitachi 7000, Japan).
T cell proliferation
To sensitize the H. pylori-specific lymphocyte population, 6-week
old female C57BL/6 mice were immunized with complete
Freund’s adjuvant and 16108 H. pylori 1:1 (vol: vol) mixture at
mouse footpads. At 5–6 days, lymphoid nodes were collected from
immunized mice and lymphocytes were used to co-culture with
PBS (mock), H. pylori-infected, heat-killed treated or IFN-c + H.
pylori-infected BMDC at 5:1 for 5 days in 96-well plate.
Lymphocyte proliferation was performed with 5-Bromo-2’-de-
oxy-uridine Labeling and Detection Kit III (Roche, USA).
Supporting Information
Figure S1 Multiplication of H. pylori in BMDCs is TLR2 and 4
independent. The BMDCs derived from TLR4 deficient (A) or
TLR2 knock-out (B) mice were infected with H. pylori at
m.o.i. = 10. The recovered viable H. pylori were determined as
CFU on CDC plate at 2, 6, 12 and 24 h post infection. Wild type
(black) and TLR mutant (gray) BMDCs were compared for their
support of bacterial replication.
Found at: doi:10.1371/journal.pone.0010844.s001 (0.25 MB TIF)
Figure S2 IFN-gamma enhances the elimination of H. pylori in
BMDCs. BMDCs were infected with H. pylori at m.o.i. = 10 for
1 h, and the IFN-gamma (100 IU/ml) was added after the
gentamicin treatment step. The recovered viable H. pylori were
determined as CFU on CDC plates at 2, 6, 12 and 24 h post
infection. * p,0.05 via student t-test.
Found at: doi:10.1371/journal.pone.0010844.s002 (0.14 MB TIF)
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